High Quality 99% Bulk Dasatinib CAS 302962-49-8 \Dasatinib Monohydrate Raw Powder CAS 863127-77-9 Anti Cancer API Chemicals

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001
• Suitable for: Elderly
• State: Solid
• Purity: >98%
• Model NO.: Dasatinib monohydrate
• Shelf Time: 3 Years
• Samples: Available
• MOQ: 1-100grams
• Color: White
• Lead Time: 1-5days
• Shipping: FedEx, DHL, TNT , Usps
• Test Report: HPLC Nmr COA Ms
• Transport Package: Al-Foil Bag
• Specification: 1bags
• Trademark: HHD
• Origin: China
• Production Capacity: 1000bags

Product Description

WE ARE MANUFACTURER!
Factory supply, Higher quality, Lower Price!!
 

Product name	Dasatinib
CAS No.	302962-49-8
Molecular formula	C22H26ClN7O2S
Molecular weight	488.01
Purity	99%
Appearance	White or almost white powder
Package	Aluminum Bag;Drums
Shelf life	2 years

99% dasatinib monohydrate powder  cas 863127-77-9

 

Product Name:	dasatinib monohydrate
CAS:	863127-77-9
MF:	C22H26ClN7O2S
MW:	488.01
EINECS:	801-607-0

Dasatinib monohydrate is a hydrate that is the monohydrate of dasatinib.
It is used for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. 
 

Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body.
 

Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Dasatinib finished drug.
Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.

Responses were maintained in 95% of patients with chronic-phase CML, with a median follow-up time of >12 months. In patients with accelerated-phase CML, 82% remained in remission, although with a median follow-up of only 5 months. Nearly all patients with CML in blast crisis or Ph+ ALL relapsed within 6 months.

Dasatinib is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+). It is taken by mouth.

Common side effects include low white blood cells, low blood platelets, anemia, swelling, rash, and diarrhea. Severe side effects may include bleeding, pulmonary edema, heart failure, and prolonged QT syndrome. Use during pregnancy may result in harm to the baby. It is a tyrosine kinase inhibitor and works by blocking a number of tyrosine kinases such as Bcr-Abl and the Src kinase family.

Dasatinib was approved for medical use in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Packaging & Shipping

Our service

1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week  for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: